Xinyuan Liu

What is he best known for?

The fields of study he is best known for:

• Gene
• Cancer
• Enzyme

His primary areas of investigation include Oncolytic adenovirus, Cancer research, Molecular biology, Genetic enhancement and Virology. Xinyuan Liu has begun a study into Oncolytic adenovirus, looking into Oncolytic virus and Cancer cell. Xinyuan Liu has included themes like Carcinogenesis, Gene, Telomerase, Adenoviridae and Adenocarcinoma in his Cancer research study.

Xinyuan Liu interconnects Apoptosis, Cell culture and Gene expression in the investigation of issues within Molecular biology. He combines subjects such as Antibody, Monoclonal antibody, Viral vector and In vivo with his study of Genetic enhancement. His Virology research is multidisciplinary, incorporating elements of Cancer, Colorectal cancer and Transgene.

His most cited work include:

• MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene (171 citations)
• Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers (170 citations)
• Cobalt chloride induces PC12 cells apoptosis through reactive oxygen species and accompanied by AP‐1 activation (158 citations)

What are the main themes of his work throughout his whole career to date?

Xinyuan Liu mostly deals with Cancer research, Oncolytic adenovirus, Molecular biology, Oncolytic virus and Apoptosis. The Cancer research study combines topics in areas such as Cancer cell, Cancer, Cell culture and Genetic enhancement. His research investigates the link between Oncolytic adenovirus and topics such as Cell growth that cross with problems in Signal transduction.

Adeno-associated virus is closely connected to Telomerase reverse transcriptase in his research, which is encompassed under the umbrella topic of Molecular biology. His Oncolytic virus research incorporates themes from Liver cancer, Prostate cancer, Viral replication and Survivin. His research integrates issues of HEK 293 cells, Hepatocellular carcinoma, Angiogenesis and Tumor suppressor gene in his study of Apoptosis.

He most often published in these fields:

• Cancer research (79.60%)
• Oncolytic adenovirus (60.40%)
• Molecular biology (42.40%)

What were the highlights of his more recent work (between 2015-2021)?

• Cancer research (79.60%)
• Oncolytic adenovirus (60.40%)
• Oncolytic virus (49.20%)

In recent papers he was focusing on the following fields of study:

Cancer research, Oncolytic adenovirus, Oncolytic virus, Apoptosis and Cell growth are his primary areas of study. He has researched Cancer research in several fields, including Viability assay, Cell culture, Cancer cell, Stem cell and Lung cancer. The concepts of his Oncolytic adenovirus study are interwoven with issues in Wnt signaling pathway, Angiogenesis, Liver cancer, Hepatocellular carcinoma and Melanoma.

His Oncolytic virus study combines topics in areas such as Molecular biology, Adenoviridae and Immunotherapy. His Apoptosis research includes elements of Tumor necrosis factor alpha and Cancer stem cell. His work carried out in the field of Cell growth brings together such families of science as Gene knockdown, PI3K/AKT/mTOR pathway, Signal transduction, Cell biology and microRNA.

Between 2015 and 2021, his most popular works were:

• Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy. (47 citations)
• SNORD126 promotes HCC and CRC cell growth by activating the PI3K-AKT pathway through FGFR2. (35 citations)
• SNORD126 promotes HCC and CRC cell growth by activating the PI3K-AKT pathway through FGFR2. (35 citations)

In his most recent research, the most cited papers focused on:

• Gene
• Cancer
• Enzyme

His main research concerns Cancer research, Oncolytic virus, Oncolytic adenovirus, Molecular biology and Apoptosis. His Cancer research study integrates concerns from other disciplines, such as PI3K/AKT/mTOR pathway, microRNA and Gene knockdown. Oncolytic virus is a subfield of Cancer that he tackles.

As part of his studies on Oncolytic adenovirus, Xinyuan Liu often connects relevant areas like Adenoviridae. His Molecular biology research is multidisciplinary, incorporating perspectives in Cell culture, Regulation of gene expression, Vaccinia and In vivo. His biological study spans a wide range of topics, including Cancer stem cell and Internal medicine, Angiogenesis, Hepatology.